The US government is considering allowing Medicare and Medicaid to cover the cost of weight loss medications. If approved, this could significantly boost sales for pharmaceutical companies like Eli Lilly and Novo Nordisk, which produce obesity drugs. However, critics argue that the high costs of these medications remain a major issue.
Source: https://www.barrons.com/articles/glp-medicare-payment-wegovy-zepbound-236464a0